ArticleAfrican health sciences2025
Clinical analysis of dexmedetomidine-esketamine combined with intranasal administration before laparoscopic high ligation of hernia sac in infants and young children.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Studying To investigate the clinical values of dexmedetomidine and esketamine combined with intranasal infusion before laparoscopic high ligation of hernia sacs in infants and young children. Methodology: In our hospital, 90Ninety children aged 8-14 years underwent surgical high ligation of the hernia sac between March 2021 and March 2022 were included. During March 2021 to March 2022, 90 children aged 8-14 underwent surgical high ligation of hernia sacs at our hospital. The study and control groups were divided. Each group had 45 cases. A routine fast was given to all the children before anesthesia, and they received midazolam for the contrast set and dexmedetomidine combined with esketamine for the examination set. The onset time, recovery time, sedation time and other indicators were analyzed. Results: The onset time of sedation in the study group was significantly lower than that in the control group, and the sedation time was significantly higher than that in the control group (P<0.05). The Ramsay score of the study group was significantly higher than that of the control group, and the difference was statistically significant (P<0.05). After sedation, the Montreal cognitive assessment (MoCA) scores of the study group was significantly lower than the control group (P<0.05). After sedation, the Ramsay score and MoCA score were significantly positively correlated (P<0.05). Conclusion: The use of Dexmedetomidine combined with esketamine nasal drops in infants and young children undergoing laparoscopic high ligation of hernia sac is an effective and safe sedation technique. It not only improves sedation but also reduces the incidence of adverse reactions. Furthermore, it does not impair the cognitive function of children. The combination of dexmedetomidine with esketamine intranasal instillation can improve sedation, reduce adverse reactions, and will not harm them. Clinical efficacy, safety, and cognitive function are high in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.